Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: Results of the German SMILe randomized, controlled implementation science trial
The SMILe-ICM appears to offer survival and rehospitalization benefits, particularly for vulnerable groups, e.g., patients living alone. Larger, adequately powered studies are needed to validate these findings.
Authors
- Sabine Valenta (ORCID: https://orcid.org/0000-0002-5598-9579)
- Lynn Leppla (ORCID: https://orcid.org/0000-0003-0233-7304)
- Juliane Mielke (ORCID: https://orcid.org/0000-0002-9771-2383)
- Sabina De Geest (ORCID: https://orcid.org/0000-0001-6596-7237)
- Robert Zeiser (ORCID: https://orcid.org/0000-0001-6565-3393)
- Alexandra Teynor (ORCID: https://orcid.org/0000-0002-8141-0428)
- Klaus Kaier (ORCID: https://orcid.org/0000-0003-0837-6945)
- Janette Ribaut (ORCID: https://orcid.org/0000-0003-0654-4052)
- Anja Schmid
Institutions
- Technische Hochschule Augsburg (DE)
- University of Freiburg (DE)
- University of Augsburg (DE)
- University of Basel (CH)
- University Medical Center Freiburg (DE)
- University Hospital of Basel (CH)
- Zimmer Biomet (Germany) (DE)
- Department of Public Health (MM)
Publication Details
- Journal
- European Journal of Oncology Nursing
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.ejon.2024.102740
- Citations
- 6
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 6.78
Funders
- Albert-Ludwigs-Universität Freiburg